Boston, Mass. —Massachusetts Eye and Ear opened a new ophthalmology (eye care) practice at 578 Main Street in Malden, Mass., on March 6. Mass. Eye and Ear, Malden is the hospital’s 19th location designed to bring the expertise of Mass. Eye and Ear specialists to the surrounding greater Boston area.
Boston, Mass. — Researchers from Schepens Eye Research Institute of Massachusetts Eye and Ear have uncovered two factors responsible for the chronic, lifelong nature of autoimmune disorders, which tend to “flare up” intermittently in affected patients. These two factors are cell-signaling proteins called cytokines—specifically Interleukin-7 and -15 (IL-7 and IL-15)—that are secreted by cells of the immune system and help modulate memory Th17 cells, a subset of T cells which are known to contribute to autoimmune disorders. Until now, it was unclear how Th17 cells maintained Read more about Researchers identify factors responsible for chronic nature of autoimmune disease
Information for this release was provided by the Association for Research in Vision and Ophthalmology.
Rockville, Md. — Vision scientists may have discovered how to reduce pedestrian collisions in crowded and chaotic open space environments like bus terminals, shopping malls and city plazas involving individuals with partial blindness. Researchers have determined from which direction collisions with partially blind pedestrians are most likely to originate. This understanding will guide the development of new glasses that expand the sight of a person with Read more about New glasses may help minimize peripheral vision loss
New findings may pave the way for the development of pharmaceutical therapies to reverse corneal scarring
Boston, Mass. — In cases of severe ocular trauma involving the cornea, wound healing occurs following intervention, but at the cost of opaque scar tissue formation and damaged vision. Recent research has shown that mesenchymal stem cells (MSCs) — which can differentiate into a variety of cells, including bone, cartilage, muscle and fat cells — are capable of returning clarity to scarred corneas; however, the mechanisms by which this Read more about Researchers shed light on repair mechanism for severe corneal injuries
The strategic licensing agreement between Lonza and Massachusetts Eye and Ear® underscores Lonza’s position as a leading AAV manufacturing service provider and offers customers unprecedented technology and services to commercialize next generation gene therapies.
The Anc-AAV vector platform has the potential to overcome pre-existing immunity in order to treat more patients compared with other viral vectors currently in development.